InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,929.04
(
2.53%
)
US TECH 100
20,273.60
(
0.25%
)
Dow Jones
43,729.93
(
3.57%
)
Brent Oil
74.56
(
-0.69%
)
Bitcoin
74,971.69
(
-0.89%
)
Post# of 253536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4751
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: NP1986 post# 125543

Tuesday, 08/23/2011 10:37:02 PM

Tuesday, August 23, 2011 10:37:02 PM

Post# of 253536
EXEL -

I just read through the slide deck presented at ASCO, and they did show the change in biomarkers for both bisphosphonate-naive and bisphosphonate-treated patients.



They also showed just as much change in CTx in the non-PC patients with no known bone mets as they did in the PC patients with known bone mets. Not saying this means the drug is not working - but the clarity is not particularly high IMO.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up